MS-20
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for MS-20, covering 2010-02-26 to 2024-12-18. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Placebo Controlled Study to Evaluate the Safety and Potential Efficacy of MS-20 in Combination with Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer [NA]